These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 18603571)

  • 21. Soluble P-selectin and CD40L levels in subjects with prediabetes, diabetes mellitus, and metabolic syndrome--the Chennai Urban Rural Epidemiology Study.
    Gokulakrishnan K; Deepa R; Mohan V; Gross MD
    Metabolism; 2006 Feb; 55(2):237-42. PubMed ID: 16423632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucose indices, health behaviors, and incidence of diabetes in Australia: the Australian Diabetes, Obesity and Lifestyle Study.
    Magliano DJ; Barr EL; Zimmet PZ; Cameron AJ; Dunstan DW; Colagiuri S; Jolley D; Owen N; Phillips P; Tapp RJ; Welborn TA; Shaw JE
    Diabetes Care; 2008 Feb; 31(2):267-72. PubMed ID: 17989310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of age on the GH-IGF1 axis in patients with acromegaly.
    Tanimoto K; Hizuka N; Fukuda I; Takano K; Hanafusa T
    Eur J Endocrinol; 2008 Oct; 159(4):375-9. PubMed ID: 18653547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of unrecognized abnormal glucose tolerance in patients attending a hospital hypertension clinic.
    Salmasi AM; Alimo A; Dancy M
    Am J Hypertens; 2004 Jun; 17(6):483-8. PubMed ID: 15177519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased arterial stiffness in subjects with impaired glucose tolerance and newly diagnosed diabetes but not isolated impaired fasting glucose.
    Li CH; Wu JS; Yang YC; Shih CC; Lu FH; Chang CJ
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E658-62. PubMed ID: 22337914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased fetuin-A concentrations in impaired glucose tolerance with or without nonalcoholic fatty liver disease, but not impaired fasting glucose.
    Ou HY; Yang YC; Wu HT; Wu JS; Lu FH; Chang CJ
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4717-23. PubMed ID: 23066121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Baseline characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial population: comparison with other diabetes prevention trials.
    Krum H; McMurray JJ; Horton E; Gerlock T; Holzhauer B; Zuurman L; Haffner SM; Bethel MA; Holman RR; Califf RM
    Cardiovasc Ther; 2010 Apr; 28(2):124-32. PubMed ID: 20184589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
    Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
    Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low serum IGF-I/GH ratio is associated with abnormal glucose tolerance in acromegaly.
    Fukuoka H; Takahashi Y; Iida K; Kudo T; Nishizawa H; Imanaka M; Takeno R; Iguchi G; Takahashi K; Okimura Y; Kaji H; Chihara K
    Horm Res; 2008; 69(3):165-71. PubMed ID: 18219220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].
    Kang Y; Lu JM; Sun JF; Li CL; Wang XL; Zhang XQ; Lü ZH; Dou JT; Mu YM
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):669-72. PubMed ID: 19595059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of non-communicable diseases among individuals with HIV infection by antiretroviral therapy status in Dar es Salaam, Tanzania.
    Kato I; Tumaini B; Pallangyo K
    PLoS One; 2020; 15(7):e0235542. PubMed ID: 32645054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and concomitants of glucose intolerance in European obese children and adolescents.
    Invitti C; Guzzaloni G; Gilardini L; Morabito F; Viberti G
    Diabetes Care; 2003 Jan; 26(1):118-24. PubMed ID: 12502667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between blood pressure and glucose tolerance in acromegaly.
    Jaffrain-Rea ML; Moroni C; Baldelli R; Battista C; Maffei P; Terzolo M; Correra M; Ghiggi MR; Ferretti E; Angeli A; Sicolo N; Trischitta V; Liuzzi A; Cassone R; Tamburrano G
    Clin Endocrinol (Oxf); 2001 Feb; 54(2):189-95. PubMed ID: 11207633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time-cumulated blood pressure exposure and incident impairment of glucose tolerance and diabetes mellitus.
    Wu YT; Song L; Liu XX; Gao JS; Zheng XM; Ruan CY; Zhao HY; Chen SH; Gao WY; Jonas JB; Wu SL
    BMC Cardiovasc Disord; 2017 May; 17(1):106. PubMed ID: 28464794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increase of classic and nonclassic cardiovascular risk factors in patients with acromegaly.
    Vilar L; Naves LA; Costa SS; Abdalla LF; Coelho CE; Casulari LA
    Endocr Pract; 2007; 13(4):363-72. PubMed ID: 17669712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Awareness of major cardiovascular risk factors and its relationship with markers of vascular aging: Data from the Brisighella Heart Study.
    Cicero AFG; Fogacci F; Tocci G; Ventura F; Presta V; Grandi E; Rizzoli E; D'Addato S; Borghi C;
    Nutr Metab Cardiovasc Dis; 2020 Jun; 30(6):907-914. PubMed ID: 32249143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of incident diabetes mellitus by baseline IGF1 levels.
    Schneider HJ; Friedrich N; Klotsche J; Schipf S; Nauck M; Völzke H; Sievers C; Pieper L; März W; Wittchen HU; Stalla GK; Wallaschofski H
    Eur J Endocrinol; 2011 Feb; 164(2):223-9. PubMed ID: 21059863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome.
    Ferrannini E; Haffner SM; Mitchell BD; Stern MP
    Diabetologia; 1991 Jun; 34(6):416-22. PubMed ID: 1884900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of blood glucose level and hypertension in Elderly Chinese Subjects: a community based study.
    Yan Q; Sun D; Li X; Chen G; Zheng Q; Li L; Gu C; Feng B
    BMC Endocr Disord; 2016 Jul; 16(1):40. PubMed ID: 27412111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased frequency of impaired fasting glucose and isolated systolic hypertension in Paget's disease of bone.
    Barale M; Cappiello V; Ghigo E; Procopio M
    Endocrine; 2019 Feb; 63(2):385-390. PubMed ID: 30284104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.